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Objective: The incidences of celiac disease (CD) and asthma are increasing and the two 
conditions are associated in individuals. Risk of asthma may be passed on to the next genera-
tion through shared risk factors. We examined whether parental CD is associated with risk of 
asthma in offspring.
Methods: We conducted a population-based Danish nationwide cohort study, using medical 
databases, covering the period 1 January 1979 to 31 December 2009. For each child with a 
parental history of CD, we randomly sampled 100 children without this history from the children 
born in the same calendar year. We used Cox proportional-hazards regression to estimate inci-
dence rate ratios for asthma, adjusting for measured covariates.
Results: We identified 1,107 children with a parental history of CD and 110,700 children with-
out this parental history. During up to 32 years of follow-up, 6,125 children received a hospital 
diagnosis of asthma. The adjusted incidence rate ratio for asthma associated with a parental 
history of CD was 1.09 (95% confidence interval: 0.86–1.39) and was similar for maternal and 
paternal CD. Inclusion of asthma-medication in the definition of asthma did not substantially 
change the results.
Conclusion: There was no convincing evidence of an increased risk of asthma among offspring 
of parents with CD.
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Introduction
Celiac disease (CD) is a chronic immune-mediated disorder associated with villous 
atrophy and inflammation of the small intestine.1 It is caused by an immune reaction 
to gluten in genetically susceptible individuals.2 The prevalence and incidence of CD 
are increasing, particularly in Europe and North America,3,4 with an estimated  current 
prevalence of 0.5%–1.5%.4,5 This trend probably results from a combination of  better 
detection and true incidence increase, presumably in response to environmental 
 exposures.4,6 The prevalence and incidence of asthma have been increasing concur-
rently with CD. Asthma is the most common chronic childhood disease in Europe, 
affecting, on average, 10% of children.7,8
While asthma is a disease with a T-helper cell type 2 expression and CD has a 
T-helper cell type 1 expression, studies have shown that the two diseases are associated 
in individuals,9–12 suggesting shared genetic risk factors. The concurrent rapid increase 
in incidence suggests that the two diseases also share environmental risk factors. 
The shared risk factors remain largely unknown, although vitamin D deficiency may 
be implicated in the development of both CD and asthma.13,14 Another consideration is 





that patients with CD may suffer from vitamin D deficiency 
as a consequence of the disease.15 Vitamin D is a critical 
regulator of the immune system and may also improve fetal 
lung growth and maturation.16 Therefore, deficiency during 
pregnancy may increase risk of asthma in offspring.16–18 
Currently, there is no epidemiologic evidence addressing the 
association between parental CD and asthma in offspring. 
We hypothesized that offspring of parents with CD have an 
increased risk of asthma. If an association is confirmed, it 
will help foster the understanding of shared risk factors. If an 
association exists only for maternal CD, it may point toward 
a pathway through maternal vitamin D deficiency. Such 
knowledge may contribute to early detection of children at 
risk of developing asthma, thus preventing under-diagnosis 
and under-treatment.7 We therefore conducted a population-
based nationwide cohort study using data linked from Danish 
medical registries.
Materials and methods
setting and study population
In this nationwide registry-based matched cohort study we 
included children born alive in Denmark from 1 January 
1979 to 31 December 2009 whose parents had a medical 
history of CD. For each child with a parental history of CD 
we randomly selected 100 children without a parental his-
tory of CD, while matching on calendar year of birth. To 
ensure that all children had a minimum of 2 years’ parental 
medical history, we only included children whose parents 
had lived in Denmark for a minimum of 2 years before the 
relevant child’s birth. The children were identified from the 
Danish Medical Birth Registry (DMBR). Follow-up started 
on the date of birth and ended on the date of asthma onset, 
emigration, death, or 31 December 2010, whichever came 
first. The DMBR has recorded all births since 1973, includ-
ing data on child, maternal, and paternal characteristics.19 
We linked individual-level data on children and their parents 
to other Danish population health registries using the civil 
personal registration (CPR) number. The CPR number is a 
10 digit unique identifier, assigned at birth or immigration 
since 1969 by the Civil Registration System and used in all 
public records.20 For children with missing father’s CPR 
number in the DMBR, we identified fathers in the Civil 
Registration System.
Data on parental CD
Data on parental CD came from the Danish National  Registry 
of Patients (DNRP).21 We searched the DNRP for CD diagno-
ses before the relevant conception for the fathers, and before 
the relevant delivery for the mothers. The DNRP has tracked 
all inpatient stays at non-psychiatric hospitals in Denmark 
since 1977. Reporting of emergency room and outpatient 
clinic contacts was added in 1995. We used inpatient, outpa-
tient or emergency room diagnoses of CD among the parents. 
The diagnoses were coded in the DNRP using the Eighth 
Revision of the International Classification of Diseases 
before 1994 and the Tenth Revision thereafter. To refine the 
CD definition, we also accessed data on biopsies recorded 
in the National Pathology Registry. The National Pathology 
Registry has a complete record of results of pathology 
 procedures since 1997, classified according to the Danish 
version of the Systemized Nomenclature of Medicine.22 
Thus, from 1997 onwards, confirmed CD biopsies were also 
used to define CD.
Data on asthma
We identified asthma in children based on inpatient, outpa-
tient, and emergency-room discharge diagnoses recorded in 
the DNRP. We defined asthma onset as the date of the first 
asthma diagnosis. Using medical records as the gold stan-
dard, the positive predictive value and sensitivity of asthma 
diagnoses in children aged 6 to 14 years has been shown to 
be 85% and 90%, respectively, in the DNRP.23
For the subgroup of children born in 1996 or later, the 
availability of prescription data from the Danish Registry of 
Medicinal Product Statistics (RMPS)24 allowed us to add an 
algorithm to the asthma definition based on a minimum of two 
dispensations of an inhaled β-agonist and a minimum of two 
dispensations of an inhaled corticosteroid, to ensure ongoing 
use. We have described and used this algorithm in previous 
studies.25–27 In this subgroup of children, we thus defined 
asthma onset as the date of the first inpatient or outpatient 
asthma diagnosis or fulfilled prescription algorithm, which-
ever came first. The RMPS has recorded all prescriptions 
filled at Danish outpatient pharmacies since 1995, including 
the type of drug prescribed (according to the Anatomical 
Therapeutic Chemical classification system) and the date of 
dispensation.24 In a study from the US, a prescription for at 
least one inhaled β-agonist and one inhaled corticosteroid has 
a positive predictive value of 80% for identifying definitive 
asthma in individuals 5–45 years of age.28
Data on covariates
Based on the existing evidence we obtained information 
on a priori selected risk factors for asthma from Danish 
medical registries.29–35 From the DMBR, we procured data 
on sex of child, birth order, birth weight, gestational age, 
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multiple gestation, mode of delivery, mother’s age at birth, 
and maternal smoking during pregnancy (recorded from 
1991). From the DNRP, we obtained hospital diagnoses of 
maternal and paternal asthma, and from the RMPS, data on 
maternal use of antibiotics during the relevant pregnancy. All 
algorithms used to define the study variables are provided 
in Table S1–S3.
statistical analyses
Descriptive statistics were used to characterize the study 
population at birth according to parental CD status. We then 
estimated the 2 year and 10 year risk of asthma, treating death 
as a competing risk.36 We used stratified Cox proportional-
hazards regression to compute crude and adjusted hazard 
ratios as estimates of incidence rate ratios (IRR and aIRR) 
with 95% confidence intervals (CI) for asthma, comparing 
children with a parental history of CD to children without 
this parental history. We examined the following categories 
of CD: parental CD, maternal CD only, and paternal CD only, 
adjusting for mode of delivery, birth order, multiple gestation, 
mother’s age at delivery, and paternal and maternal asthma. 
The proportional-hazards assumption was assessed graphi-
cally and found to apply (Figures S1–S7).
Since some patients may have symptoms for several years 
before being diagnosed with CD,37 we repeated the analyses 
changing the parental medical history time window from a 
minimum of 2 years to a minimum of 10 years prior to their 
child’s birth.
Because hospital-diagnosed asthma may represent the 
most severe disease, in another sensitivity analysis, we 
restricted the sample to children born in 1996 or later, in 
order to include the anti-asthma medication algorithm in 
the definition of asthma. This analysis included additional 
adjustment for maternal smoking and use of antibiotics 
during pregnancy. Finally, since asthma can be difficult to 
diagnose in small children,38 we conducted the analyses start-
ing follow-up at age five years, both for the full cohort and 
for the restricted cohort of children born in 1996 or later, to 
allow inclusion of the anti-asthma medication algorithm and 
additional adjustment.
We used Stata software version 12 to analyze the data 
(StataCorp LP, College Station, TX, USA). The study was 
approved by the Danish Data Protection Agency (record no 
2013-41-1790).
Results
We identified 1,107 children with parental history of CD 
and 110,700 children without such a parental history of 
CD, matched by year of birth. Maternal CD accounted 
for 69% of all parental CD. First-born status, parental 
asthma, and maternal use of antibiotics were slightly 
more prevalent among children with parental CD than 
among those without (Table 1). All children contrib-
uted 806,332 person-years of follow-up and the median 
follow-up time was 7.4 years.
Table 1 Characteristics of children born in Denmark in 
1979–2009 according to parental celiac disease (n=111,807)
Characteristics Parental  
celiac disease  
(n=1,107)
No parental  
celiac disease  
(n=110,700)
n % n %
Parental celiac disease
 Maternal 759 68.6
 Paternal 348 31.4
sex of child
 Male 568 51.3 56,742 51.3
 Female 539 48.7 53,958 48.7
Birth ordera
 1 536 48.4 48,149 43.5
 $2 571 51.6 62,551 56.5
Birth weight (grams)
 ,2,500 58 5.2 5,751 5.2
 2,500–3,499 501 45.3 46,558 42.1
 $3,500 543 49.1 57,914 52.3
 Missing 5 0.5 477 0.4
gestational age (weeks)
 ,37 68 6.1 7,133 6.4
 37–41 967 87.4 95,432 86.2
 $42 66 6.0 7,543 6.8
 Missing 6 0.5 592 0.5
Mode of delivery
 Vaginal 864 78.1 89,067 80.5
 Cesarean section 243 21.9 21,633 19.5
Multiple gestation
 Yes 33 3.0 4,565 4.1
Mother’s age at birth (years)
 ,25 156 14.1 14,518 13.1
 25–34 852 76.0 82,332 74.4
 $35 99 8.9 13,850 12.5
Maternal asthma
 Yes 39 3.5 2,648 2.4
Paternal asthma
 Yes 43 3.9 2,235 2.0
(n=982) (n=98,200)
Maternal use of antibiotics during pregnancyb
 Yes 355 36.1 31,857 32.4
Maternal smoking during pregnancyb
 no 815 83.0 78,525 80.0
 #10 cigarettes/day 107 10.9 12,451 12.7
 .10 cigarettes/day 40 4.1 4,289 4.4
 Missing 20 2.0 2,935 3.0
Notes: aChildren of multiple births are coded in the same birth order; bchildren 
born from 1996 onwards.





During up to 32 years of observation, 68 children with 
parental CD and 6,057 children without this parental history 
had an asthma diagnosis. The median age at asthma onset 
was 1.5 years in both cohorts. When follow-up was started 
at the age of 5 years, the median age of asthma onset was 
7.4 years. The 2-year risk of asthma in the full cohort was 
4.3% among children with a parental history of CD and 3.6% 
among children without this parental history; the 10-year 
risks were 7.4% and 6.4%, respectively (Figure 1).
Overall, the aIRR for asthma associated with parental CD 
was 1.09 (95% CI: 0.86–1.39), with nearly no effect from 
adjustment for the covariates. Results did not vary according 
to maternal or paternal CD (Table 2).
In the sub-cohort of children born in 1996–2009, for 
whom we included anti-asthma medication in the asthma 
definition, we identified 982 children with a parental history 
of CD and 98,200 without this history. During up to 15 years 
of follow-up, 129 children with parental CD developed 
asthma compared to 11,120 children without parental CD. 
The aIRR for parental CD was 1.14 (95% CI: 0.95–1.35), 
with similar estimates for maternal and paternal CD (other 
results not shown).
Changing the time window for a parental medical history 
of CD from a minimum of 2–10 years before their child’s 
birth did not change the results. Finally, starting follow-up 
at age five in the full cohort and in children born in 1996 
or later also did not substantially affect the results (data not 
shown).
Discussion
In this nationwide population-based cohort study with long-
term complete follow-up and prospectively collected data, 
we found no convincing evidence for an association between 
parental CD and risk of asthma. The results were robust to 
different approaches to measuring the study variables and 
our study thus argues against a pathway of shared risk factors 
from parent to the next generation.
To the best of our knowledge, our study is the first 
to examine the association between parental CD and the 
risk of asthma in offspring. The association between CD 
and asthma within the same individuals has been exam-
ined in previous studies. Kero et al, in a cohort study of 
59,867 children, including 114 children with CD, reported 
an adjusted relative risk of asthma in children with CD of 
7.26 (95% CI: 4.49–11.01).12 Hemminki et al, using data 
from 3,006 patients hospitalized with asthma, reported a 
standardized incidence ratio for subsequent hospitaliza-
tion with CD of 1.97 (95% CI: 1.64–2.34).11 In a Swedish 
matched cohort study, including 28,281 individuals with CD 
and 140,295 individuals without CD, the hazard ratio for 
asthma associated with CD was 1.61 (95% CI: 1.50–1.72).10 
Still, although examining a different association, our results 
are consistent with two previous studies examining family 
associations of CD and asthma. An Italian study compared 
the prevalence of allergies, including asthma, in individuals 
with CD (n=1,044) with that of their CD-free first-degree 
relatives and spouses.39 The authors reported that no 
statistically significant difference in asthma prevalence 
was observed. Also, a small Italian case control study of 
82 children with CD and 180 children without, reported 
no statistically significant difference in asthma prevalence 
among relatives of the two groups.40 Neither of the studies 
reported relative estimates. The observed association of the 
two conditions in the same individual9–12 might be explained 
by host genetics and their interaction with environmental 
factors or vitamin D deficiency, with subsequent inability 
to control regulatory T-cell responses.10 Although our study 
argues against it, we cannot reject that CD and asthma share 
risk factors, however, a pathway from parent to child is not 
very likely.
The strengths of our study are its population-based cohort 
design with long-term and complete follow-up and use of 
prospectively collected data from population-based medical 
databases. The setting of a universal, tax-funded health care 
and routine registration of the events of interest virtually 
removes selection bias. We were also able to control for 
several important risk factors of asthma, including parental 
asthma and maternal smoking during pregnancy.
An important limitation of our study may be potential 
misclassification of the study variables. CD may have a silent 
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Figure 1 absolute risk of asthma in children according to parental celiac disease 
(CD) status.
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a gluten-free diet,37 however, our results did not substantially 
change after extending the minimum parental medical history 
requirement from 2 years to 10 years. Any misclassification 
is likely to be non-differential with respect to development of 
asthma in offspring, and will bias the risk estimates toward 
the null. Misclassification of asthma among small children 
may also occur, and since we would expect it to be unrelated 
to parental CD, it may have produced bias toward the null if 
a true association existed. However, as our results were the 
same when we started follow-up at age five years, bias from 
misclassification of the asthma diagnosis does not appear to 
be of major importance.
We cannot completely rule out bias from unknown and 
unmeasured confounding, but to explain the lack of an 
observed association, a potential confounder would need to 
be protective of asthma. Breastfeeding may protect against 
development of both asthma and CD,41 and women with 
CD may have an increased awareness of the importance 
of breastfeeding. However, data on this variable are not 
recorded in Danish registries. Also, we lacked information 
on maternal use of vitamin supplements. It would be valuable 
to examine risk of asthma in children of mothers with treated 
CD during pregnancy (ie, CD diagnosed more than 1 year 
before pregnancy) versus mothers who were untreated dur-
ing pregnancy. Finally, despite large sample size, precision 
of the estimates was suboptimal owing to small number of 
events among children with parental CD.
In conclusion, in this nationwide cohort study, we found 
no evidence of an association between parental CD and 
asthma in offspring.
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Abbreviation: aTC, anatomical Therapeutic Chemical.









Abbreviation: ICD, International Classification of Diseases.
Table S3 snOMED-codes
Diagnosis SNOMED code
Celiac disease T64020 + M58018 
T65110 + M58018 
T64310 + M58018 
s62180




















































































































































Figure S5 Proportional-hazards assumption – birth order.
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Figure S6 Proportional-hazards assumption – mode of delivery.
